The company aims to provide services in the pharmaceutical and life science sectors, including all related or ancillary activities. Additionally, it provides consulting, training, and speaking services, particularly on digital assets and their technologies (e.g., DLT) as well as treasury, compliance, and process-related issues. The company does not accept public deposits and does not provide financial services to third parties, including individual investment advice, asset management, and transaction brokerage. The company may establish branches and subsidiaries domestically and abroad, and may participate in other companies domestically and abroad, as well as conduct all business directly or indirectly related to its purpose. The company may acquire, encumber, dispose of, and manage real property domestically and abroad. It may also undertake financing for its own account and provide security for the liabilities of affiliated companies; furthermore, it may acquire, hold, and dispose of its own financial investments, including digital or electronically represented assets. It may acquire, manage, and dispose of copyrights, patents, and licenses.